Home > Insider Trading > Kinnate Biopharma Inc.

Kinnate Biopharma Inc. (KNTE)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

Displaying 5

13 Hot Penny Stocks To Buy According to Hedge Funds

The overall market optimism helped by expectations that the Fed might start cutting interest rates in 2024 is helping riskier assets and equities, including small-cap stocks, penny stocks and cryptocurrencies...

Keep Reading →

December 6th, 2023 - Hedge Funds News

11 Stocks with Heavy Insider Buying in 2023

Insider trading activity has always invited interest and controversy from investors and authorities.

Keep Reading →

May 22nd, 2023 - Hedge Funds Insider Trading News

Harvard University's Latest Portfolio: 10 Best Biotech Stock Picks

In this article, we will look at Harvard University's latest stock portfolio and list its 10 best biotech stock picks.

Keep Reading →

September 15th, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: David Rosen, David Einhorn, Carl Icahn, Brevan Howard Asset Management, Man Group, Archegos Capital Management, Kinnate Biopharma Inc (KNTE), and More

David Einhorn enjoyed a strong fourth quarter as his hedge fund Greenlight Capital outperformed the S&P 500's 11% gain by returning 18.6%, according to the billionaire investor's latest 13F filing.

Keep Reading →

February 16th, 2022 - Hedge Funds Insider Trading